Description: Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the wholesale and retail sale of Chinese medicines and healthcare products; technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; and internal and external surgery, medical examination, and traditional Chinese medicine department and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.
Home Page: www.tongrentangkj.com
No.20 Nansanhuan Zhonglu Road
Beijing,
100079
China
Phone:
86 10 8763 2888
Officers
| Name | Title |
|---|---|
| Mr. Jia Fu Chen | GM & Executive Director |
| Ms. Zhi Mei Feng | Deputy GM & Executive Director |
| Mr. Shu Bing Di | Executive Chairman of the Board |
| Mr. Guan Zhao Han | Deputy GM & General Legal Counsel |
| Mr. Yijun Li | Company Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 8.5714 |
| Price-to-Book MRQ: | 0.8324 |
| Price-to-Sales TTM: | 0.1149 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4005 |